The 2024 Greater Bay Area Multinational Pharmaceutical Company Symposium was held on Monday in Guangzhou, south China's Guangdong province. The event convened government officials, executives from 24 multinational pharmaceutical companies—including 20 China-based presidents and 40 vice presidents and department heads—and several innovative local pharmaceutical enterprises.
Participants engaged in in-depth discussions on shared interests, collaborative opportunities, and the development potential of the biomedical industry in the Guangdong-Hong Kong-Macao Greater Bay Area.
Representatives of multinational companies praised Guangdong's remarkable achievements in advancing its biopharmaceutical sector. They recognized the province's pioneering role in China’s reform and innovation efforts, emphasizing its potential to become a leading hub for biomedical innovation. The discussions also highlighted the importance of strengthening partnerships to foster the high-quality development of the biopharmaceutical and health industries.